{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:16:15Z","timestamp":1760955375248},"reference-count":14,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2012.06.006","type":"journal-article","created":{"date-parts":[[2012,7,21]],"date-time":"2012-07-21T00:50:45Z","timestamp":1342831845000},"page":"846-850","source":"Crossref","is-referenced-by-count":9,"title":["Rate of Antithrombotic Drug use and Clinical Outcomes According to CHADS2 Scores in Patients With an Initial Cardioembolic Stroke who had Nonvalvular Atrial Fibrillation"],"prefix":"10.1016","volume":"22","author":[{"given":"Ichiro","family":"Deguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuko","family":"Ohe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Nemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Tanahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2012.06.006_bib1","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: The Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.06.006_bib2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0002-9343(99)80348-9","article-title":"The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the Manitoba Follow-Up Study","volume":"98","author":"Krahn","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.06.006_bib3","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.06.006_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.06.006_bib5","series-title":"Japanese Guidelines for the Management of Stroke 2009","first-page":"31","year":"2009"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.06.006_bib6","series-title":"Japanese stroke databank","author":"Fukuda","year":"2009"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.06.006_bib7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1253\/circj.68.417","article-title":"Attitudes of Japanese cardiologists toward anticoagulation for nonvalvular atrial fibrillation and reasons for its underuse","volume":"68","author":"Inoue","year":"2004","journal-title":"Circ J"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.06.006_bib8","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3995\/jstroke.33.551","article-title":"The trend in antithrombotic therapy for cardioembolic stroke due to non-valvular atrial fibrillation [in Japanese with English abstract]","volume":"33","author":"Taguchi","year":"2011","journal-title":"Jpn J Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.06.006_bib9","first-page":"26","article-title":"Pre-admission CHADS2 score in patients with cardioembolic stroke due to atrial fibrillation: Should Japanese clinicians consider warfarin therapy for the patients with CHADS2 score of 1? [in Japanese]","volume":"6","author":"Sato","year":"2011","journal-title":"J Cardiol Jpn Ed"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.06.006_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3995\/jstroke.32.129","article-title":"CHADS2 score is not related to neurological severity or outcome of stroke in patients with NVAF [in Japanese with English abstract]","volume":"32","author":"Anegawa","year":"2010","journal-title":"Jpn J Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.06.006_bib11","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.thromres.2006.12.019","article-title":"Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy","volume":"120","author":"Partington","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.06.006_bib12","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1161\/CIRCULATIONAHA.106.653048","article-title":"Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation","volume":"115","author":"Hylek","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.06.006_bib13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.thromres.2007.05.014","article-title":"Risk of bleeding in very old atrial fibrillation patients on warfarin: Relationship with ageing and CHADS2 score","volume":"121","author":"Poli","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2012.06.006_bib14","unstructured":"Japanese Circulation Society web site. Guidelines for pharmacotherapy of atrial fibrillation (JCS 2008). Available from http:\/\/www.j-circ.or.jp\/english\/activities\/pdf\/gl\/satoshi_ogawa2008.pdf. Accessed June 30,\u00a02012."}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305712001991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305712001991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T01:21:11Z","timestamp":1542849671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305712001991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S1052305712001991"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2012.06.006","relation":{},"ISSN":["1052-3057"],"issn-type":[{"value":"1052-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}